baber/WOPTO huggingface dataset:
Patent AU-2021204745-B2 (AU)
Title: Transcatherer atrial sealing skirt, anchor, and tether and methods of implantation
Inventor: RAJAGOPAL VIVEK
IPC: A61B17/08
Filed: 2021-07-07
Granted: 2021-11-04
Abstract: A medical assembly implanting an atrial sealing skirt in the heart at an atrial sealing skirt 
deployment site and related methods of implantation and delivery. An anchor is 
endovascularly introduced into the heart and implanted to a cardiac wall with an anchor 
delivery system and delivery cable. A second delivery system introduces a tether which 
coupled to the implanted anchor and an atrial sealing skirt. The atrial sealing skirt includes a 
top brim which is positioned to conform to the atrial floor at the deployment site. The sealing 
skirt may be integrated with a valve or serve as a receptacle.
Patent AU-2021206820-B2 (AU)
Title: Therapeutic compositions
Inventor: RAU THOMAS F
IPC: A61K31/19
Filed: 2021-07-20
Granted: 2023-07-27
Abstract: Compositions of fatty acids (e.g., including one or more C4 to C40 fatty acids, such as a C4 to 
C20 fatty acid) and one or more amino acids (and particularly one or more amino acids having electrically 
charged basic side chains, e.g., Arginine, Lysine, etc.) for use as an anti-pathogenic composition. These 
5 compositions may find particular use as anti-bacterial and in some variations anti-viral, anti-fungal and 
anti-cancer compositions.
Patent AU-2022201725-B2 (AU)
Title: Reverse acid and hydrocarbon cascading in alkylation
Inventor: LIU ZAN
IPC: C07C7/00
Filed: 2022-03-11
Granted: 2023-05-25
Abstract: A cascade reactor scheme with acid and hydrocarbon flowing in reverse 
directions. The systems and processes for alkylation of olefins herein may include providing a 
first olefin to a first alkylation zone, and a second olefm to a second alkylation zone. Isoparaffin 
may be provided to the first alkylation zone. The isoparaffm and first olefin may be contacted 
with a partially spent sulfuric acid in the first alkylation zone to form a spent acid phase and a 
first hydrocarbon phase including alkylate and unreacted isoparaffin. The first hydrocarbon 
phase and second olefin may be contacted with a sulfuric acid feed in the second alkylation 
zone to form a second hydrocarbon phase, also including alkylate and unreacted isoparaffin, 
and the partially spent sulfuric acid that is fed to the first alkylation zone. Further, the second 
hydrocarbon phase may be separated, recovering an isoparaffin fraction and an alkylate product 
fraction.
Patent JP-4304837-B2 (JP)
IPC: C12N9/10
Filed: 2000-07-05
Granted: 2009-07-29
Abstract: L-Glutamic acid is produced by culturing a coryneform bacterium having L-glutamic acid producing ability, in which trehalose synthesis ability is decreased or deleted by, for example, disrupting a gene coding for trehalose-6-phosphate synthase, a gene coding for maltooligosyltrehalose synthase, or both of these genes to produce and accumulate L-glutamic acid in the medium, and collecting the L-glutamic acid from the medium.
Patent JP-3619133-B2 (JP)
IPC: G11B17/04
Filed: 2000-08-31
Granted: 2005-02-09
Abstract: The present invention provides a disk loading apparatus the thickness of which can be reduced and which is applicable to disks of diverse size. An apparatus according to the invention comprises: an out-lever unit (509) which is arranged in a slot for a disk to be inserted and thereby retains the outer edge of the disk so as to permit the disk inserted into the slot to pass through the slot; a roller unit (503) for transferring the disk to a predetermined position; a check plate unit (506) which is arranged in the interior from the slot and thereby retains the outer edge of the disk transferred by the roller unit (503); and a disk motor 17 for rotating the disk at the predetermined position. <IMAGE>
Patent JP-5450915-B2 (JP)
IPC: G04G99/00
Filed: 2000-12-28
Granted: 2014-03-26
Abstract: The invention relates to a method for detemining an error in the reference time (15) of a receiver (MS) in positioning means (S, MS). In the method, a code modulated signal transmitted by satellites (SV1-SV4) is received the signal being formed with an individual code for each satellite (SV1-SV4). In the method, the time (T/< ANd> k_ToT) of transmission of the signal received from every satellite used in the positioning is determined to be used in determining the position of the satellite. To determine a difference between the time (T/< ANd> k_ToT) of transmission of the signal and the reference time, positioning is performed, and on the basis of the determined position, an error value (ERR) is calculated. Thus, in the method, a minimum point of the error value is searched for by determining the position of the receiver (MS) with at least two different positions of the satellite corresponding to the time of transmission and by calculating the error value (ERR) for said at least two determined positions of the receiver (MS). <IMAGE>
Patent JP-4204188-B2 (JP)
IPC: C08J7/048
Filed: 1998-07-14
Granted: 2009-01-07
Abstract: The invention concerns composite polyester films with good barrier properties relative to gases. More precisely, it concerns a biaxially drawn film, based on polyester and having improved barrier properties relative to gases, characterised in that it comprises a base polyester film of 5 to 50 mum, coated on one of its two surfaces with a deposit containing polyvinyl alcohol and a water dispersible copolyester with sulphonyloxy units, said composite film having permeability to oxygen measured at 23° C. under 50% relative humidity, not more than 5 cm3/m2/24 h. Said composite films have, besides being transparent and having barrier properties, excellent resistance to mechanical stresses, such as in particular crumpling.
Patent JP-4318399-B2 (JP)
IPC: C12N15/09
Filed: 1998-09-18
Granted: 2009-08-19
Abstract: The vaccines and methods of the present invention are based on deletion mutations in the protein transmembrane domains of membrane-enveloped viruses. The strategy for production of these mutations is based on the fact that unlike mammalian cell membranes, the membranes of insect cells contain no cholesterol; thus are thinner than mammalian membranes. Many membrane-coated viruses have membrane glycoproteins on their surface which are responsible for identifying and infecting target cells. These membrane glycoproteins have hydrophobic membrane-spanning domains which anchor the proteins in the membrane bilayer. The membrane-spanning domains of these transmembrane proteins must be long enough to reach from one side of the bilayer to the other in order to hold the proteins in the membrane. Provided is a vaccine, a method of producing this vaccine, and a method of using this vaccine, based on the differences between membranes of viruses replicated in invertebrates and membranes of viruses replicated in vertebrates.
Patent JP-4401021-B2 (JP)
IPC: G01N21/35
Filed: 1999-02-04
Granted: 2010-01-20
Abstract: The present invention relates to a method of producing an electric, electronic, electromechanical and/or mechanical component (12), where the component substrate is given a three-dimensional structure (3'') or configuration, and where said substrate is adapted for further treatment or processing to form the component (12). The substrate is formed by shaping said substrate against a die or mold, such as by molding, pressing, extruding or embossing said substrate, wherewith the precision necessary with respect to said component in the three-dimensional structure is achieved by means of a micromechanical working process when producing the die or mold.
Patent JP-4511725-B2 (JP)
IPC: H01M10/52
Filed: 1999-03-22
Granted: 2010-07-28
Abstract: A catalytic hydrogen/oxygen recombination unit (1) for batteries has a space (6) connected to the battery connection channel by an opening and to the atmosphere by an ignition suppressing element.
Patent JP-4087568-B2 (JP)
IPC: A61F2/30
Filed: 1998-10-15
Granted: 2008-05-21
Abstract: The present invention is directed to a vertebral bone prosthetic device comprising an interior body, provided with an outer surface and a first coupling element thereon, and an exterior hollow body with a bore therein extending along a central axis, with the interior body being configured and dimensioned to be slidably received by the exterior body along the central axis, and provided with an interior surface and an exterior surface, the interior surface having a groove. The device also comprises a fixation ring having inner and outer surfaces, with the inner surface having a second coupling element thereon. The fixation ring is configured and dimensioned to be received within the groove of the exterior body for rotational movement about the central axis of the exterior body. Rotation of the fixation ring results in engagement of the first and second coupling elements to thereby prevent relative sliding movement between the interior and exterior bodies. Also, the fixation ring is rotatable between first second positions, the first position disengaging the coupling elements and allowing relative sliding movement and the second position engaging the coupling elements and blocking relative sliding movement.
Patent JP-4932991-B2 (JP)
IPC: C12Q1/6883
Filed: 1999-11-24
Granted: 2012-05-16
Abstract: The present invention relates to methods and compositions for treating Alzheimer's disease and other diseases and conditions with an inflammatory component (e.g., central nervous system injury). In particular, the present invention provides agents that regulate the production of proinflammatory and neurotoxic products involved in Alzheimer's disease and other diseases and conditions with an inflammatory component.
Patent JP-4463993-B2 (JP)
IPC: A61K6/896
Filed: 2000-02-09
Granted: 2010-05-19
Abstract: The present invention relates to a molding that has a layer of copolymers that are crosslinkable by means of addition or condensation reactions and, optionally, thereon, a layer of silicone that is crosslinkable by means of addition or condensation reactions.
Patent JP-4155712-B2 (JP)
IPC: H04L9/30
Filed: 2000-02-10
Granted: 2008-09-24
Abstract: For a set (Lk) of embedded systems, an authorized operator with identifier (OP<SUB>j</SUB>) creates a mother public key (KpM) and a mother private key (KsM). The identifier (OP<SUB>j</SUB>), the range of identifiers referenced (Lk) and the mother public key (KpM) are published. For each embedded system (SN<SUB>i</SUB>), a diversified key (KsM<SUB>i</SUB>) is created from the identifier (SN<SUB>i</SUB>) and stored. For every public key (Kp) generated by an embedded system, a cryptographic control value (Sc<SUB>i</SUB>) is calculated on the public key (Kp), an algorithm identifier (CA 1 ) and the utilization parameters (U) of this key, using a zero knowledge signature algorithm, and a certification request message (MRCA) that includes control value (Sc<SUB>i</SUB>), the identifier of the operator (Op<SUB>j</SUB>), and identifier (SN<SUB>i</SUB>) is transmitted to a certification authority, which retrieves the identifier (Op<SUB>j</SUB>) and the value of the mother public key (KpM).
Patent JP-4679727-B2 (JP)
IPC: B01J19/00
Filed: 2000-02-25
Granted: 2011-04-27
Abstract: A self sealing vessel assembly for high pressure microwave assisted chemistry is disclosed. The vessel assembly includes a polymeric cylinder (12) and a circular polymeric cap (13) for the cylinder, the cylinder being closed at one end and open at the other end to receive the cap. The open end of the cylinder has a lip that is bevelled inwardly from the open end, and the circular polymeric cap (13) has a bevelled lower edge that engages the bevelled lip when the cap (13) is placed upon the polymeric cylinder (12). For high pressure applications, a choke cylinder depends from the bevelled lower edge of the cap, and has an outer diameter substantially the same as the inner diameter of the polymeric cylinder (12) so that the choke provides a self sealing mechanism for the cylinder as pressure from a chemical reaction increases within the cylinder. A supporting frame (14) extends along the cylinder (12) and across the lid (13) and across the closed end of the cylinder, and prevents the lid from being displaced from the cylinder when pressure is generated inside of the vessel. <IMAGE>
Patent JP-4521592-B2 (JP)
IPC: H04B10/25
Filed: 2001-02-15
Granted: 2010-08-11
Abstract: A method of setting up two-way optical communication between a central unit and a remote unit suitable for operating in a given communication mode selected from a plurality of communication modes. A plurality of frame patterns is defined in the central unit, with each frame pattern being appropriate to one of the communication modes. The plurality of frame patterns are sent sequentially until a coherent response is obtained from the remote unit, the communication mode of the remote unit being the mode which corresponds to the frame pattern which gave rise to the coherent response.
Patent JP-3587380-B2 (JP)
IPC: A61P31/04
Filed: 2001-06-26
Granted: 2004-11-10
Abstract: This invention relates to compounds of the formula <CHEM> and to pharmaceutically acceptable salts, prodrugs, and solvates thereof wherein X, Y, R<1>, R<2>, R<3>, R<4>, and R<6> are as defined herein. The compounds of formula I are antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula I, methods of making the compounds, and to methods of treating bacterial and protozoal infections by administering the compounds.
Patent JP-4948718-B2 (JP)
IPC: C03C25/00
Filed: 2001-08-17
Granted: 2012-06-06
Abstract: A method for reducing the hydrogen aging loss of silica optical fibers by irreversible reaction of the peroxide defects with deuterium is described. This method comprises the step of contacting the optical fiber with deuterium by exposure to a gas mixture containing deuterium at a temperature compatible with the fiber without exposing the fiber to any further activation, and subsequently the step of degassing the fiber in a neutral atmosphere. The invention relates further a process of producing optical fibers with low hydrogen aging loss wherein an optical fiber is treated using the method for reducing the hydrogen aging loss. Finally, the invention relates to optical fibers with low hydrogen aging loss obtainable by this process and telecommunication cables produced using these optical fibers. Using the new method, an activation step using intense light and/or elevated temperature is not necessary to achieve the reaction of peroxide defects in silica with deuterium. The process according to the invention allows reaction at temperatures such as the ambient temperature without any further activation.
Patent JP-3767807-B2 (JP)
IPC: C08F226/02
Filed: 2001-12-13
Granted: 2006-04-19
Abstract: <P>PROBLEM TO BE SOLVED: To provide an image forming material having no unevenness in coating, a smooth coated surface state, a uniform layer thickness, no irregular color, no repellency, no pinhole and excellent adhesiveness to a glass substrate.  <P>SOLUTION: In the image forming material obtained by disposing coating layers comprising at least an alkali-soluble thermoplastic resin layer and a photosensitive resin layer in this order on a support, a copolymer comprising monomers of formulae (a)-(c) is contained in at least one of the thermoplastic resin layer and the photosensitive resin layer. In the formulae, R<SB>01</SB>-R<SB>07</SB>are each H or a 1-5C alkyl; R<SB>1</SB>is a single bond or a linking group containing at least one selected from O, N and S; R<SB>2</SB>is a single bond or a linking group containing at least one selected from C, O, N and S; n is an integer of 1-20; m is an integer of 2-14; and l is an integer of 0-10.  <P>COPYRIGHT: (C)2003,JPO
Patent JP-4571358-B2 (JP)
IPC: A61M25/00
Filed: 2000-06-22
Granted: 2010-10-27
Abstract: The invention provides a method and system for treatment for body structures, especially internal body structures involving unwanted features or other disorders, that does not require relatively invasive surgery, and is not subject to other drawbacks noted with regard to the known art. A relatively minimally invasive catheter including a contained cooling element is inserted into the body. The distal and proximal end of the catheter are extended or retracted or some combination thereof so as to achieve optimal delivery of treatment. Treatment of the body structures is applied using the electrodes embedded in the cooling element, and the unwanted features or disorders are relatively cured using the applied treatments. In a preferred embodiment, the applied treatments can include application of energy or substances, including application (such as of radio frequency energy, microwave energy, or laser or other electromagnetic energy) or substances (such as collagen or other bulking, plumping, or shaping agents; saline or other energy-receiving electrolytes; astringents or other debulking, reducing, or shaping agents; antibiotics or other bioactive, chemoactive, or radioactive compounds). In a preferred embodiment, more than one applied treatment can be performed, either in conjunction, in parallel, or seriatim, so as to achieve a combined effect more substantial than any one individual such applied treatment.
Patent JP-4898054-B2 (JP)
IPC: B29C43/02
Filed: 2001-03-06
Granted: 2012-03-14
Abstract: A process for compression moulding semi-crystalline polymers, comprising the following operations: bringing the material to a temperature exceeding the polymer melting point TF; cooling the material to a temperature TLAV close to but higher than the temperature TIC at which crystallization commences during cooling; feeding measured quantities of material into a mould operating by compression; forming the article while maintaining a temperature close to TIC; cooling the article and extracting it from the mould.
Patent JP-4813734-B2 (JP)
IPC: G01N33/15
Filed: 2001-03-30
Granted: 2011-11-09
Abstract: The invention features methods of promoting hair growth in a subject. The methods include inducing or mimicking the effects of Wnt promoted signal transduction, e.g., by increasing the level of Wnt protein or administering an agent which mimics an effect of Wnt promoted signal transduction, e.g., by administering lithium chloride. Methods of inhibiting hair growth are also provided.
Patent JP-3774152-B2 (JP)
IPC: B65B25/14
Filed: 2002-01-25
Granted: 2006-05-10
Abstract: A device for packing a product (2) in a sheet (4) of packing material, the product (2) and the sheet (4) being fed into the device in a given feed direction (D1) with the sheet (4) folded about the product (2) in order to have a portion (77) projecting upstream from the product (2) in the feed direction (D1); the device being defined by a drum (38) rotating about an axis (39) perpendicular to the feed direction (D1) and supporting two belt conveyors (40) parallel to and facing each other to grip the product (2) and the sheet (4) of packing material and by fixed folding members (74) for folding the portion (77) into contact with the product (2) during rotation of the drum (38) about the axis (39). <IMAGE>
Patent JP-4056261-B2 (JP)
IPC: H01R39/18
Filed: 2002-02-28
Granted: 2008-03-05
Abstract: A planar carbon segment commutator comprises a commutator base 10 of insulating material. The base has a rotational axis and front and rear surfaces, extending, at least in part, transversely to the rotational axis. A plurality of apertures 16 extend through the base. The commutator also comprises a plurality of commutator terminals 20 each of which comprises a terminal portion 21 and a contact portion 22. The contact portion 22 of each terminal extends through a respective aperture 16 and is bent to lie against or in close proximity to the front surface of the base 10. The terminal portion of each terminal has two cutting edges for cutting insulation on a connector portion of a winding and a slot which in use straddles and grips the connector portion. The commutator also comprises a plurality of carbon segments 30 formed on the front surface of the base and over the contact portions 22, respectively, of the terminals 20 and a housing (Figure 9) having a plurality of housing recesses for receiving the terminal portions 21, respectively, of the terminal. <IMAGE>
Patent JP-4469551-B2 (JP)
IPC: A61P37/08
Filed: 2001-06-15
Granted: 2010-05-26
Abstract: A transgenic non-human mammal or its offspring which carries DNA having exogenous caspase 1 gene integrated thereinto in such a manner as to express the gene specifically to skin. In view that the transgenic non-human mammal of the present invention spontaneously develops atopic dermatitis in the absence of any specific pathogenic microorganism, the mammal is useful as a disease model animal. Use of the transgenic animal of the present invention enables development of preventive and/or therapeutic drugs for atopic dermatitis based on natural immunity and to clarify the onset mechanism of atopic diseases.
Patent JP-3944079-B2 (JP)
IPC: A61B17/12
Filed: 2001-11-07
Granted: 2007-07-11
Abstract: An implant for occluding a passage in a circulatory system is provided. The implant in one form includes a plurality of thin wire-like members each having a proximal and a distal end and a first holder to which the distal ends of the members are attached. The proximal ends of the members are attached to a second holder. The implant includes an expansible occluding body attached to the members at a point intermediate the first and second holders. A carrier rod is releasably attached to the first holder and upon which the second holder is slidably received. A driving implement is located on the carrier rod, the driving implement contacting the second holder and movable toward the first holder along the carrier rod. The members are attached to the first and second holders in a manner to cause the members to execute a twisting motion relative to the longitudinal axis to yield a plurality of generally radially extending loops combining to form a first fixation structure adjacent the distal face of the occluding body, and a second fixation structure of generally radially extending loops adjacent the proximal face of the occluding body. In another form, the implant includes a balloon structure which is expanded from within by a spring-like mechanism in situ, or by the foregoing radially extending loop mechanism.
Patent JP-4100172-B2 (JP)
IPC: C08K3/00
Filed: 2001-12-12
Granted: 2008-06-11
Abstract: Disclosed are a varnish for laminate or prepreg, comprising a heat treatment product which is obtained by mixing together (a) an epoxy resin, (b) dicyandiamide, and (c) a compound having an imidazole ring so that the component (c) is present in an amount of 0.001 to 0.03% by weight, based on the weight of the component (a), and subjecting the resultant mixture to reaction for heat treatment in an organic solvent at a temperature of 70 DEG C to less than 140 DEG C so that all of the components are compatible with one another in the absence of a solvent; and (d) inorganic filler, a laminate or prepreg prepared using the varnish and a printed wiring board prepared using the laminate and/or prepreg.
Patent JP-4198992-B2 (JP)
IPC: C01B9/08
Filed: 2001-12-21
Granted: 2008-12-17
Abstract: The invention relates to a fluorination process for producing fluorinated compounds. The process consists in reacting a compound (I) corresponding to the formula with an ionic fluoride of a monovalent cation. M represents H, an alkali metal, a quaternary phosphonium group or a quaternary ammonium group. Y represents SO<SUB>2 </SUB>and m is 1, or else Y is PO and m is 2. Z represents CR<SUP>2</SUP>, N or P. R<SUP>1 </SUP>represents an electron-withdrawing group which has a Hammet sigma<SUB>P </SUB>parameter of greater than 0.4. R<SUP>2 </SUP>represents a carbonaceous and/or electron-withdrawing group. X represents a halogen other than a fluorine. The fluorinated compounds obtained are of use in particular as electrolytes in lithium batteries.